Funding focus: Biotech dominates Netherlands’ top 10 rounds in H1 2025

Funding focus: Biotech dominates Netherlands’ top 10 rounds in H1 2025


Funding focus is a new series analysing cash flow into the European tech ecosystem. After debuting with a look at the biggest rounds so far this year, we now turn to the largest deals in the Netherlands for H1. Startups in the Netherlands raised just $503mn (€429mn) in the first quarter of this year — the lowest quarterly total since the early days of the COVID-19 pandemic, according to Dealroom data. But three months later, the outlook has improved. Total funding for the first half of 2025 hit $1.4bn (€1.2bn). That’s down from $1.8bn (€1.54bn) at the same point last…

This story continues at The Next Web
  1. No comment added yet!
  2. Leave Your Comment

    Your email address will not be published. Required fields are marked *

AtSign Innovations